Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexei Livenskyi

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Molecular Biology|January 24, 2024
Interference Requirements of Type III CRISPR-Cas Systems from Thermus thermophilusKaryna Karneyeva, Matvey Kolesnik, Alexei Livenskyi, et al.
Nucleic Acids Research|May 24, 2022
GNAT toxins evolve toward narrow tRNA target specificitiesDmitry Bikmetov, Alexander M J Hall, Alexei Livenskyi, et al.
Science Advances|April 24, 2024
tRNA anticodon cleavage by target-activated CRISPR-Cas13a effectorIshita Jain, Matvey Kolesnik, Konstantin Kuznedelov, et al.
Nucleic Acids Research|June 30, 2020
Mechanism of translation inhibition by type II GNAT toxin AtaT2Stepan V Ovchinnikov, Dmitry Bikmetov, Alexei Livenskyi, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 4, 2025
Specificity and mechanism of tRNA cleavage by the AriB Toprim nuclease of the PARIS bacterial immune systemSvetlana Belukhina, Baptiste Saudemont, Florence Depardieu, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Viral proteins activate PARIS-mediated tRNA degradation and viral tRNAs rescue infectionNathaniel Burman, Svetlana Belukhina, Florence Depardieu, et al.
Nature|August 7, 2024
A virally encoded tRNA neutralizes the PARIS antiviral defence systemNathaniel Burman, Svetlana Belukhina, Florence Depardieu, et al.
Biochemistry. Biokhimiia|December 7, 2025
A Unique Mechanism of Glycine-Specific Inhibition of Bacterial Translation by Bottromycin A<sub>2</sub>Inna A Volynkina, Aleksandr A Grachev, Alexei Livenskyi, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Molecular Biology|January 24, 2024
Interference Requirements of Type III CRISPR-Cas Systems from Thermus thermophilusKaryna Karneyeva, Matvey Kolesnik, Alexei Livenskyi, et al.
Nucleic Acids Research|May 24, 2022
GNAT toxins evolve toward narrow tRNA target specificitiesDmitry Bikmetov, Alexander M J Hall, Alexei Livenskyi, et al.
Science Advances|April 24, 2024
tRNA anticodon cleavage by target-activated CRISPR-Cas13a effectorIshita Jain, Matvey Kolesnik, Konstantin Kuznedelov, et al.
Nucleic Acids Research|June 30, 2020
Mechanism of translation inhibition by type II GNAT toxin AtaT2Stepan V Ovchinnikov, Dmitry Bikmetov, Alexei Livenskyi, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 4, 2025
Specificity and mechanism of tRNA cleavage by the AriB Toprim nuclease of the PARIS bacterial immune systemSvetlana Belukhina, Baptiste Saudemont, Florence Depardieu, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Viral proteins activate PARIS-mediated tRNA degradation and viral tRNAs rescue infectionNathaniel Burman, Svetlana Belukhina, Florence Depardieu, et al.
Nature|August 7, 2024
A virally encoded tRNA neutralizes the PARIS antiviral defence systemNathaniel Burman, Svetlana Belukhina, Florence Depardieu, et al.
Biochemistry. Biokhimiia|December 7, 2025
A Unique Mechanism of Glycine-Specific Inhibition of Bacterial Translation by Bottromycin A<sub>2</sub>Inna A Volynkina, Aleksandr A Grachev, Alexei Livenskyi, et al.
Pageof 1